These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7195402)

  • 1. Isolation and properties of a plasminogen activator derived from canine vascular tissue.
    Highsmith RF
    J Biol Chem; 1981 Jul; 256(13):6788-95. PubMed ID: 7195402
    [No Abstract]   [Full Text] [Related]  

  • 2. Isolation and characterization of plasminogen activators from hyperplastic and malignant prostate tissue.
    Kirchheimer J; Köller A; Binder BR
    Biochim Biophys Acta; 1984 Feb; 797(2):256-65. PubMed ID: 6199043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purification and characterization of a plasminogen activator secreted by cultured human pancreatic carcinoma cells.
    Wu M; Arimura GK; Yunis AA
    Biochemistry; 1977 May; 16(9):1908-13. PubMed ID: 15590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and characterization of human kidney plasminogen activator dissimilar to urokinase.
    Sueishi K; Nanno S; Okamura T; Inoue S; Tanaka K
    Biochim Biophys Acta; 1982 Aug; 717(2):327-36. PubMed ID: 7052141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial purification and characterization of native plasminogen activators from bovine milk.
    Deharveng G; Nielsen SS
    J Dairy Sci; 1991 Jul; 74(7):2060-72. PubMed ID: 1894805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen-activator in human early milk: its partial purification and characterization.
    Okamoto U; Horie N; Nagamatsu Y; Yamamoto JI
    Thromb Haemost; 1981 Apr; 45(2):121-6. PubMed ID: 7196095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and characterization of human vascular plasminogen activator.
    Aasted B
    Biochim Biophys Acta; 1980 Feb; 621(2):241-54. PubMed ID: 7188733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-chain urokinase-type plasminogen activator: mechanism of action and thrombolytic properties.
    Lijnen HR; Stump DC; Collen DC
    Semin Thromb Hemost; 1987 Apr; 13(2):152-9. PubMed ID: 3114883
    [No Abstract]   [Full Text] [Related]  

  • 9. Partial purification and some properties of the tissue plasminogen activator from the human myometrium.
    Soszka T
    Thromb Res; 1977 Jun; 10(6):823-32. PubMed ID: 18814
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on plasminogen activator from pig kidney cell cultures. III. Purification and characterization.
    Bobbitt JL; Clavin SA; Hutchins JF; Arnett GC; Hull RN
    Thromb Res; 1980 May 1-15; 18(3-4):315-32. PubMed ID: 7191148
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of black cohosh on the plasminogen activator system in vascular smooth muscle cells.
    Lee DY; Roh CR; Kang YH; Choi D; Lee Y; Rhyu MR; Yoon BK
    Maturitas; 2013 Sep; 76(1):75-80. PubMed ID: 23827472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of chlorpropamide and gliclazide on plasminogen activator activity in vascular walls in patients with maturity onset diabetes.
    Almér LO
    Thromb Res; 1984 Jul; 35(1):19-25. PubMed ID: 6433503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and characterization of a urokinase-type plasminogen activator (Mr = 54,000) from cultured human endothelial cells indistinguishable from urinary urokinase.
    Booyse FM; Osikowicz G; Feder S; Scheinbuks J
    J Biol Chem; 1984 Jun; 259(11):7198-205. PubMed ID: 6539333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vampire bat salivary plasminogen activator.
    Gardell SJ; Friedman PA
    Methods Enzymol; 1993; 223():233-49. PubMed ID: 8271956
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulation of plasminogen activator activity in the endothelium. Influence of local factors.
    Risberg B
    Bibl Anat; 1979; (18):114-5. PubMed ID: 496807
    [No Abstract]   [Full Text] [Related]  

  • 16. Isolation and properties of human vascular plasminogen activator.
    Allen RA; Pepper DS
    Thromb Haemost; 1981 Feb; 45(1):43-50. PubMed ID: 7195611
    [No Abstract]   [Full Text] [Related]  

  • 17. Fish plasminogen activators: their identification and characterization.
    Takahashi K; Wakamatsu Y; Ozato K; Wakayama Y
    Cell Struct Funct; 1987 Feb; 12(1):11-22. PubMed ID: 3552260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and properties of a plasminogen activator from cultured rat prostate adenocarcinoma cells.
    Strickland DK; de Serrano VS; Chan SY; Pollard M; Castellino FJ
    Biochemistry; 1983 Sep; 22(19):4444-9. PubMed ID: 6684952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of multiple types of plasminogen activator inhibitors from vascular smooth muscle cells.
    Laug WE; Aebersold R; Jong A; Rideout W; Bergman BL; Baker J
    Thromb Haemost; 1989 Jun; 61(3):517-21. PubMed ID: 2799763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active and pro-plasminogen activator on the surface of human bladder cancer cells derived from a high grade invasive tumour.
    Grant AJ; Russell PJ; Raghavan D
    Biochem Biophys Res Commun; 1990 Oct; 172(2):870-6. PubMed ID: 2173583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.